DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivo.
The ditriazine derivative DTD (4,10-dichloropyrido[5,6:4,5]thieno[3,2-d':3,2-d]-1,2,3-ditriazine) has been previously reported to reduce the degree of granulomatous inflammation and vascular density in a murine air pouch granuloma model. The aim of this study was to test whether DTD affects angiogenesis. Our results show that DTD inhibits in vivo angiogenesis in the chorioallantoic membrane (CAM) assay at doses equal or lower than 0.3 nmol/egg. Different in vitro assays were used to study the potential effects of this compound on key steps of angiogenesis, namely, a colorimetric assay of cell proliferation/viability, a morphogenesis on Matrigel assay, zymographic assays for gelatinases and nuclear morphology and cell cycle analysis for apoptosis induction. Our data indicate that DTD inhibits proliferation but does not induce apoptosis in endothelial cells in vitro. DTD suppresses the endothelial capillary-like chord formation at concentrations lower than those required to inhibit proliferation. DTD treatment inhibits the matrix metalloproteinase-2 production in endothelial and fibrosarcoma cells, but does not affect the cyclooxygenase-2 expression in endothelial cells, as assessed by western blot analysis. Taken together, results here presented indicate that DTD exhibits an anti-angiogenic activity that is independent of inflammatory processes and make it a promising drug for further evaluation in the treatment of angiogenesis-related pathologies.
Martínez-Poveda
Beatriz
B
Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, Málaga, Spain.
Muñoz-Chápuli
Ramón
R
Riguera
Ricardo
R
Fernández
Antonio
A
Medina
Miguel Angel
MA
Quesada
Ana R
AR
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000737:chemistry / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001681:Biological Assay; D002417:Cattle; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002645:Chickens; D049033:Chorioallantoic Membrane / Q000187:drug effects / Q000378:metabolism; D017077:Culture Media, Conditioned; D051546:Cyclooxygenase 2 / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D018093:Gelatinases / Q000378:metabolism; D006801:Humans; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D014227:Triazines / Q000737:chemistry / Q000494:pharmacology*
C412523:4,10-dichloropyrido(5,6:4,5)thieno(3,2-d')-1,2,3-ditriazine; D000893:Anti-Inflammatory Agents; D017077:Culture Media, Conditioned; D014227:Triazines; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D018093:Gelatinases
Int J Biochem Cell Biol. 2001 Oct;33(10):960-70
11470230
Naunyn Schmiedebergs Arch Pharmacol. 2002 May;365(5):357-64
12012021
Nat Med. 1997 Nov;3(11):1203-8
9359693
Trends Mol Med. 2003 Feb;9(2):73-8
12615041
J Cell Mol Med. 2007 May-Jun;11(3):374-82
17635633
Cancer Metastasis Rev. 2000;19(1-2):19-27
11191059
FASEB J. 2002 Feb;16(2):261-3
11772945
Cell. 2000 Jan 7;100(1):57-70
10647931
Nat Med. 2003 Jun;9(6):653-60
12778163
Cell Mol Life Sci. 2004 Sep;61(17):2224-43
15338053
J Immunol. 2003 Mar 15;170(6):3369-76
12626597
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
6606682
Anticancer Res. 2000 May-Jun;20(3A):1691-4
10928093
J Clin Oncol. 2001 Feb 15;19(4):1195-206
11181686
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3884-9
10760260
Br J Cancer. 1994 Feb;69(2):212-6
8297716
Bioorg Med Chem. 1998 Oct;6(10):1911-25
9839021
Biochem Biophys Res Commun. 2007 Feb 2;353(1):152-8
17174275
Int J Cancer. 2004 May 20;110(1):31-8
15054866
J Cell Physiol. 1993 Aug;156(2):235-46
8344982
Int J Cancer. 2005 Dec 10;117(5):775-80
15981212
Nature. 2005 Dec 15;438(7070):932-6
16355210
Med Res Rev. 2006 Jul;26(4):483-530
16652370
Dev Biol. 1995 Jul;170(1):39-49
7601314
Prog Exp Tumor Res. 2003;37:179-92
12795055
Nat Med. 2003 Jun;9(6):669-76
12778165
FASEB J. 2000 Dec;14(15):2477-85
11099465
Nat Rev Drug Discov. 2007 Apr;6(4):273-86
17396134
Biochem Biophys Res Commun. 2004 Jul 23;320(2):402-8
15219842
J Cell Biol. 1988 Oct;107(4):1589-98
3049626
Cell. 1989 Sep 8;58(5):933-43
2528412
Eur J Pharmacol. 2000 May 26;397(1):207-17
10844115
Anticancer Res. 2001 Sep-Oct;21(5):3457-60
11848509
Cell Growth Differ. 1998 Apr;9(4):305-12
9563850
Bioessays. 2007 Nov;29(11):1159-68
17935210